The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
PKA catalytic subunit mutations in adrenocortical Cushing’s adenoma impair association with the regulatory subunit
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In vivo studies revealed that the catalytic activity of PKA-CL205R is comparable to that of wild type (12).”
From Cushing’s syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity (2019) · cites this paper as [12]
In the citing paper
“On the basis of its positioning, the L205R mutation has been proposed and shown by independent laboratories to disrupt the binding of R-subunits and render the enzyme constitutively active (12, 13).”
From Cushing’s syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity (2019) · cites this paper as [12]
In the citing paper
“This is in line with the impaired binding of the R-subunits found in our previous study (12) as PKI and R-subunits share similar consensus sequences.”
From Cushing’s syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity (2019) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kirschner, L. S., Carney, J. A., Pack, S. D., Taymans, S. E., Giatzakis, C., Cho, Y. S., Cho-Chung, Y. S., & Stratakis, C. A. (2000) · Nature Genetics · doi:10.1038/79238 · Cited by 1,153
Regulation of the synthesis of steroidogenic enzymes in adrenal cortical cells by ACTH
Simpson, E. R., & Waterman, M. R. (1988) · Annual Review of Physiology · doi:10.1146/annurev.ph.50.030188.002235 · Cited by 506
Activating hotspot L205R mutation in PRKACA and adrenal Cushing’s syndrome
Cao, Y., He, M., Gao, Z., Peng, Y., Li, Y., Li, L., Zhou, W., Li, X., Zhong, X., Lei, Y., et al. (2014) · Science · doi:10.1126/science.1249480 · Cited by 232
Rothenbuhler, A., Horvath, A., Libé, R., Faucz, F. R., Fratticci, A., Raffin Sanson, M. L., Vezzosi, D., Azevedo, M., Levy, I., Almeida, M. Q., et al. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04366.x · Cited by 96
Research works printed but not linked: 25
- Taylor, S. S., Ilouz, R., Zhang, P. & Kornev, A. P. Assembly of allosteric macromolecular switches: lessons from PKA. Nat. Rev. Mol. Cell Biol. 13, 646–658 (2012). · DOI · Paper page
- Lyons, J. et al. Two G protein oncogenes in human endocrine tumors. Science 249, 655–659 (1990). · DOI · Paper page
- Parma, J. et al. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365, 649–651 (1993). · DOI · Paper page
- Vallar, L., Spada, A. & Giannattasio, G. Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature 330, 566–568 (1987). · DOI · Paper page
- Landis, C. A. et al. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 340, 692–696 (1989). · DOI · Paper page
- Weinstein, L. S. et al. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N. Engl. J. Med. 325, 1688–1695 (1991). · DOI · Paper page
- Carney, J. A., Young, W. F. & Stratakis, C. A. Primary bimorphic adrenocortical disease: cause of hypercortisolism in McCune-Albright syndrome. Am. J. Surg. Pathol. 35, 1311–1326 (2011). · DOI
- Bertherat, J. et al. Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity. Cancer Res. 63, 5308–5319 (2003).
- Horvath, A. et al. A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. Nat. Genet. 38, 794–800 (2006). · DOI · Paper page
- Horvath, A., Mericq, V. & Stratakis, C. A. Mutation in PDE8B, a cyclic AMP-specific phosphodiesterase in adrenal hyperplasia. N. Engl. J. Med. 358, 750–752 (2008). · DOI · Paper page
- Beuschlein, F. et al. Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome. N. Engl. J. Med. 370, 1019–1028 (2014). · DOI · Paper page
- Goh, G. et al. Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors. Nat. Genet. 46, 613–617 (2014). · DOI · Paper page
- Sato, Y. et al. Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome. Science 344, 917–920 (2014). · DOI · Paper page
- Moore, M. J., Adams, J. A. & Taylor, S. S. Structural basis for peptide binding in protein kinase A. Role of glutamic acid 203 and tyrosine 204 in the peptide-positioning loop. J. Biol. Chem. 278, 10613–10618 (2003). · DOI
- Yang, J. et al. Allosteric network of cAMP-dependent protein kinase revealed by mutation of Tyr204 in the P+1 loop. J. Mol. Biol. 346, 191–201 (2005). · DOI
- Zhang, P. et al. Structure and allostery of the PKA RIIbeta tetrameric holoenzyme. Science 335, 712–716 (2012). · DOI · Paper page
- Bechtel, P. J., Beavo, J. A. & Krebs, E. G. Purification and characterization of catalytic subunit of skeletal muscle adenosine 3′:5′-monophosphate-dependent protein kinase. J. Biol. Chem. 252, 2691–2697 (1977). · doi:10.1016/s0021-9258(17)40514-x
- Dao, K. K. et al. Epac1 and cAMP-dependent protein kinase holoenzyme have similar cAMP affinity, but their cAMP domains have distinct structural features and cyclic nucleotide recognition. J. Biol. Chem. 281, 21500–21511 (2006). · DOI
- Zaccolo, M. et al. A genetically encoded, fluorescent indicator for cyclic AMP in living cells. Nat. Cell Biol. 2, 25–29 (2000). · DOI · Paper page
- Zaccolo, M. & Pozzan, T. Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes. Science 295, 1711–1715 (2002). · DOI · Paper page
- Ramachandran, J., Tsubokawa, M. & Gohil, K. Corticotropin receptors. Ann. NY Acad. Sci. 512, 415–425 (1987). · doi:10.1111/j.1749-6632.1987.tb24977.x
- Roger, P. P., Reuse, S., Maenhaut, C. & Dumont, J. E. Multiple facets of the modulation of growth by cAMP. Vitam. Horm. 51, 59–191 (1995). · DOI
- Rosenberg, D. et al. Role of the PKA-regulated transcription factor CREB in development and tumorigenesis of endocrine tissues. Ann. NY Acad. Sci. 968, 65–74 (2002). · DOI · Paper page
- Lindholm, J. et al. Incidence and late prognosis of Cushing's syndrome: a population-based study. J. Clin. Endocrinol. Metab. 86, 117–123 (2001).
- Clegg, R. M. Fluorescence resonance energy transfer and nucleic acids. Methods Enzymol. 211, 353–388 (1992). · DOI · Paper page
Cited by
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma
Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., Lerario, A. M., Else, T., Knijnenburg, T. A., Ciriello, G., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.04.002 · Cited by 657
Self-citationLou, J., Jiao, Y., Yang, R., Huang, Y., Xu, X., Zhang, L., Ma, Z., Yu, Y., Peng, W., Yuan, Y., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2209218119 · Cited by 351
Genetic landscape of sporadic unilateral adrenocortical adenomas without PRKACA p.Leu206Arg mutation
Ronchi, C. L., Di Dalmazi, G., Faillot, S., Sbiera, S., Assié, G., Weigand, I., Calebiro, D., Schwarzmayr, T., Appenzeller, S., Rubin, B., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1586 · Cited by 93
Self-citationGenetics of tumors of the adrenal cortex
Bonnet-Serrano, F., & Bertherat, J. (2018) · Endocrine Related Cancer · doi:10.1530/erc-17-0361 · Cited by 80
Walker, C., Wang, Y., Olivieri, C., Karamafrooz, A., Casby, J., Bathon, K., Calebiro, D., Gao, J., Bernlohr, D. A., Taylor, S. S., et al. (2019) · Science Advances · doi:10.1126/sciadv.aaw9298 · Cited by 71
Self-citation
Metadata
- Authors
- Calebiro, D., Hannawacker, A., Lyga, S., Bathon, K., Zabel, U., Ronchi, C., Beuschlein, F., Reincke, M., Lorenz, K., Allolio, B., Kisker, C., Fassnacht, M., & Lohse, M. J.
- Venue
- Nature Communications
- Published
- 2014-12-05
- Volume
- 5
- Issue
- 1
- ISSN
- 2041-1723
- Cited by
- 77
- References
- 4
- Language
- en
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.